Sponsor:
Eli Lilly and Company
Code:
NCT05999994
Conditions
Neoplasms
Child
Adolescent
Eligibility Criteria
Sex: All
Age: 1 - 39
Healthy Volunteers: Not accepted
Interventions
Ramucirumab
Cyclophosphamide
Vinorelbine
Gemcitabine
Docetaxel
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations